MAPRX — MainStay MAP Equity Fund
Data updated: 2026-09-23
MAPRX — MainStay MAP Equity Fund. United States Multi-Cap / All-Cap Blend / Core Equity · $902.54M AUM. Holdings, fees, performance and SEC filings.
MAPRX Fund Overview
MAPRX — MainStay MAP Equity Fund is a US mutual fund managed by New York Life Investments Funds, categorised as United States Multi-Cap / All-Cap Blend / Core Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: New York Life Investments Funds
- Category: United States Multi-Cap / All-Cap Blend / Core Equity
- Assets under management: $902.54M
- 1-year return: 3.6%
- Ticker: MAPRX
- SEC CIK: 0000787441
- SEC series ID: S000006906
- Share class ID: C000018734
MAPRX Investment Objective and Strategy
MainStay MAP Equity Fund describes its objective and strategy as follows, from its latest prospectus filed with the SEC by New York Life Investments Funds.
Investment objective
The Fund seeks long-term appreciation of capital.
Principal investment strategy
"Under normal conditions, the Fund invests at least 80% of its assets (net assets plus any borrowings for investment purposes) in equity securities. Equity securities include common stocks, and securities convertible into, or exchangeable for, common stocks, across all market capitalizations. The Fund may also invest in foreign securities, which are generally securities issued by companies organized outside the U.S. and that are traded primarily in markets outside the United States. The Fund employs two subadvisors, Epoch Investment Partners, Inc. (""Epoch"") and Markston International LLC (""Markston""), with investment processes and styles that New York Life Investment Management LLC, the Fund's Manager, believes are complementary. Each Subadvisor is responsible for managing a portion of the Fund's assets, as designated by the Manager from time to time.
Investment Process: The Subadvisors' investment processes and styles are as follows: Epoch: Epoch invests primarily in companies that generate free cash flow and have managements that allocate it effectively to create shareholder value. MainStay MAP Equity Fund The security selection process focuses on free-cash-flow analytics as opposed to traditional accounting-based metrics. Epoch seeks to identify companies with a consistent, straightforward ability to both generate free cash flow and to intelligently allocate it among internal reinvestment opportunities, acquisitions, dividends, share repurchases and/or debt reduction. Epoch may sell or reduce a position in a security when it believes its investment objectives have been met or when the security is deemed less attractive relative to another security on a return/risk basis.
Epoch may sell or reduce a position in a security if it sees the investment thesis failing to materialize. Markston: Markston seeks to identify companies that it believes can emerge as market leaders, where current valuation is disconnected from positive long-term prospects and ultimately have the potential to develop premium valuations. In addition to applying existing valuation criteria like low multiples of price-to-book or cash flow, Markston looks for companies with identifiable catalysts, including insider buying, stock repurchases, management change, sale or spin-off of a division, industry consolidation, and tax loss carry-forwards. Markston generally looks for the presence of at least three of these catalysts to coincide with what it believes could enhance the return potential of a stock while also helping to minimize risk.
Markston also assesses the judgment, quality, and integrity of company management and the track record of capital deployment. Finally, Markston will apply a rigorous discounted cash flow model as an important valuation tool in both buy and sell decisions. Under normal circumstances, Markston holds securities for a relatively long period of time. However, certain securities may be acquired from time to time in an effort to earn short-term profits. Markston may sell an investment when it believes the opportunity for current profits or the risk of market decline outweighs the prospect of future capital gains."
MAPRX Holdings
Top 10 holdings of MainStay MAP Equity Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Microsoft Corp. | 6.60% |
| JPMorgan Chase & Co. | 3.57% |
| Johnson & Johnson | 2.67% |
| Merck & Co., Inc. | 2.51% |
| Cisco Systems, Inc. | 2.19% |
| UnitedHealth Group, Inc. | 2.19% |
| Elevance Health, Inc. | 1.79% |
| Diamondback Energy, Inc. | 1.78% |
| Intercontinental Exchange, Inc. | 1.75% |
| U.S. Foods Holding Corp. | 1.71% |
MAPRX Portfolio Allocation
Asset-class allocation of MainStay MAP Equity Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.6% |
| Cash & Equivalents | 0.6% |
MAPRX Performance
Total returns for MAPRX (as of 2026-10-01), from SEC filings.
| Period | Total return |
|---|---|
| 1 year | 3.6% |
| 3 years (annualised) | 9.4% |
MAPRX Risk Information
Risk metrics for MAPRX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 14.7%
MAPRX Costs and Fees
MAPRX costs about $87 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.87%
- Gross expense ratio: 0.87%
- Portfolio turnover: 43%
- Brokerage commissions: 2.24 bps of average net assets (SEC N-CEN)
MAPRX Cashflows
Over the 12 months to 2026-04, MainStay MAP Equity Fund had net outflows of $108.31M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-04 | −$25.78M |
| 2026-03 | −$9.48M |
| 2026-02 | −$12.24M |
| 2026-01 | −$9.44M |
| 2025-12 | $46.05M |
| 2025-11 | −$20.37M |
MAPRX Debt Constituents
No individual debt constituents are reported in MainStay MAP Equity Fund's latest SEC N-PORT filing.
MAPRX Prospectus and SEC Filings
Official MainStay MAP Equity Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2026-02-26
- Prospectus (485BPOS) — filed 2025-02-25
- Prospectus supplement (497) — filed 2025-02-28
- Portfolio holdings (N-PORT) — filed 2026-09-23
- Portfolio holdings (N-PORT) — filed 2026-06-25
- Portfolio holdings (N-PORT) — filed 2026-03-26
- Annual census (N-CEN) — filed 2026-01-13
- Annual census (N-CEN) — filed 2025-01-13
Related Funds
Other United States Multi-Cap / All-Cap Blend / Core Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.